-
Rosalind Ramsey-GoldmanNorthwestern Univ.USA
-
Rosalind Ramsey-Goldman, MD, DrPH, is the Gallagher Research Professor of Rheumatology at Northwestern University Feinberg School of Medicine (NUFSM) and an attending physician for Northwestern Medicine. She has been a member of the Systemic Lupus International Collaborating Clinics, SLICC, group for over twenty years. She succeeded Dr. Isenberg as chair in 2004. Dr. Ramsey-Goldman is the director of the Patient-Oriented Clinical Research Program in lupus with continuous funding from NIH, foundations, philanthropy, and industry since 1991 when she joined the faculty at NUFSM. Her research program examines risk factors to minimize complications in lupus including pregnancy, osteoporosis, malignancy, renal, and cardiovascular disease. Through national and international collaborations, she studies genetic risk factors for disease severity/susceptibility; collaborates on investigations studying pathogenesis of disease; develops disease classification criteria, flare assessments, nephritis guidelines, disease impact (damage and frailty), assessment of patient-reported outcomes (including an investigator-initiated NIAMS/NIH funded clinical trial testing an intervention to mitigate fatigue, a pervasive problem affecting 90% of patients with lupus), and developed computable phenotype tools to detect SLE patients in the electronic medical record (including DoD impact grant award, “EHR-based Longitudinal Cohort to Explore Pregnancy Outcomes in SLE (ELIPTCL)” applying these tools in the Chicago Area Patient-Centered Outcomes Research Network, CAPriCORN to map outcomes of interest and risk factors examining disease severity and morbidity in SLE pregnancy using a common data model). Many of these clinical investigations incorporate analysis of lupus in multiethnic cohorts examining clinical, laboratory, and health related outcomes. An underlying theme for these investigations is a longstanding interest in documenting health disparities in lupus and experience working with communities and she was recently awarded an investigator-initiated NIAMS funded clinical trial, “Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases.”
Research & Clinical Focus
systemic lupus erythematosus
pregnancy in rheumatic disease
patient-reported outcomes
computable phenotypes
clinical trials
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| May 18 | 13:00-13:20 | Room Auditorium | [Concurrent Session 1] Global Challenges | Global epidemiology of SLE: Do we need more than just counts? |
